Tornoe joins Exagen Diagnostics

Wednesday, August 10, 2011 11:09 AM

Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.

Tornoe has more than 20 years of healthcare industry experience. He previously worked for Pfizer, Wyeth and Bristol-Myers Squibb, quickly advancing his career in a number of senior management positions that dramatically expanded revenues.  

"Eric has a great track record in leading and directing teams to exceed corporate business and revenue objectives. He will play an instrumental role in the ongoing success of the company and its continued focus on personalized medicine,” said Scott Glenn, board chairman and CEO.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs